Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 14.75 billion as of February 21, 2025. Its market cap has decreased by -24.12% in one year.

Market Cap

14.75B

Enterprise Value

12.57B

Revenue

31.76M

Ranking

n/a

PE Ratio

n/a

Stock Price

116.50

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 14.75B, an increase of 66.34%. That is a compound annual growth rate of 6.53%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	14.75B	2.64%
Dec 31, 2024	14.37B	-31.28%
Dec 29, 2023	20.91B	-42.13%
Dec 30, 2022	36.13B	16.16%
Dec 30, 2021	31.10B	17.15%
Dec 31, 2020	26.55B	222.07%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	213.05B
Caliway Biopharmaceuticals	142.70B
Bora Pharmaceuticals Co., LTD.	90.22B
Lotus Pharmaceutical	72.97B
Lumosa Therapeutics	39.69B
Oneness Biotech	38.96B
Polaris Group	34.55B
Pegavision	30.65B

Market Cap Rankings